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in 1999, a series of studies have provided compelling evidence that patients undergoing high-risk operations should receive β-blockers before surgery. 2 Given these findings, the Surgical Care Improvement Project required that all patients previously receiving β-blockers should receive their medication in the 24 hours before surgery. More recently, however, several large-scale studies have failed to reproduce these beneficial effects, 3, 4 and the Perioperative Ischemic Evaluation trial 4 found increased mortality with the use of β-blockers before surgery.
A similar controversy exists with regard to the perioperative administration of statins, agents that may reduce cal Care Improvement Project or into the recommendations from professional societies. In the present study, we aim to determine whether treatment with β-blockers, statins, or both before cardiac surgery is associated with a reduction in the risk of adverse events after surgery.
Methods | This study was a retrospective review of our institution's Society of Thoracic Surgeons database including all adult patients undergoing cardiac surgery between 2008 and 2014 (N = 3826). Patients were divided into 4 groups: no treatment, treatment with β-blockers alone, treatment with statins alone, and treatment with both statins and β-blockers, in the 24 hours preceding surgery. Patients were excluded if they were treated with extracorporeal membrane oxygenation, used ventricular assist devices, received a transplant, had a prior history of arrhythmia, trauma, minor procedures (defined as surgery time of <90 minutes), preoperative intubation, offpump cases, and incomplete records. Demographic or clinical variables found to have modest significance on univariate analysis (P < .20) were included in a multivariate regression model and are listed in Table 1 . The primary end point was inhospital mortality, while several secondary outcomes (including length of hospital stay, prolonged mechanical ventilation, reoperation for bleeding, postoperative atrial fibrillation, renal failure, and cardiac arrest) were considered. Findings were considered to be statistically significant if P < .05. The study protocol was approved by the institutional review board at the University of California, Los Angeles, and waiver of consent was obtained.
Results | A total of 1930 patients met the inclusion criteria and were divided as follows: 424 patients were treated with β-blockers alone (22%), 278 patients were treated with statins alone (14%), 766 patients were treated with both statins and β-blockers (40%), and 462 patients received no treatment (24%). Group characteristics are displayed in Table 1 . After adjustment for baseline differences, mortality rates were similar among all patient groups. No significant differences were seen in secondary outcome measures with either use of β-blockers alone or use of statins alone. However, when compared with the patients who received no treatment, the patients who were treated with both statins and β-blockers had lower rates of prolonged hospitalization (adjusted odds ratio, 0. Table 2) .
Discussion | Once a mainstay of therapy, perioperative β-blockade has recently been questioned as appropriate therapy for cardiac surgery patients. The present study also failed to demonstrate improvements in postoperative outcomes with the preoperative administration of β-blockers alone. After adjustment for patient risk factors and differences between treatment groups, we found that the coadministration of β-blockers with statins was associated with improvements in duration of ventilation, length of hospital stay, and the need for reoperation for bleeding. Mechanistically, both classes of medications may reduce the oxidative stress, and β-blockers may reduce the adrenergic surge associated with cardiac surgery. Our study has several limitations inherent to its retrospective nature. Baseline differences in the characteristics of treatment groups were accounted for using a multivariate model. In addition, our study was not powered to perform subgroup analyses on, for example, coronary bypass operations. Current evidence, although limited, suggests that combination therapy with statins and β-blockers should be considered as a quality metric for cardiac surgery. Future prospective randomized studies are warranted to assess the effects of this combination therapy in larger cohorts. 
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Survey of the Deficits in Surgeons' Knowledge of Contralateral Prophylactic Mastectomy
The contralateral prophylactic mastectomy (CPM) rate has increased dramatically over the past decade. The reasons for this trend are multiple but include patient misperceptions about the risk of contralateral breast cancer (CBC) and how a CPM affects recurrence and survival. 1, 2 Little is known, however, about surgeons' knowledge of CPM and CBC and how this informs medical decision making. The literature on these topics is continually evolving, but definitive outcomes data and recommendations for CPM are lacking. Because surgeons are most patients' preferred source of medical information regarding breast cancer, 1 we thought it prudent to examine surgeons' knowledge of CPM. We hypothesized that surgeons' knowledge of CPM is variable and represents an opportunity for improved education on the topic.
Methods | Between December 2013 and February 2014, we emailed a survey to 2436 active members of the American Society of Breast Surgeons, obtaining 592 responses (24.3%). The survey assessed demographics, training, practice characteristics, and knowledge. For knowledge, we presented 2 clinical cases and 3 factual questions developed by breast surgeons and medical oncologists ( Table 1) . We dichotomized responses into "low" (0-3 correct) and "high" (4-5 correct) knowledge categories and tabulated frequencies. Logistic regression was used to examine which demographic factors predicted a "high level" of knowledge. Institutional review board approval was waived by the authority of NorthShore University HealthSystem in Evanston, Illinois. The surgeons completing the survey did not provide informed consent because the data were deidentified. P < .05 was considered statistically significant.
Results | Of the 592 surgeons who completed the survey, 224 (37.8%) had completed fellowship training, 350 (59.1%) were in private practice, 352 (59.5%) were male, and 343 (57.9%) devoted at least 80% of their practice to breast disease. Table 1 lists knowledge questions and answer options that were used in the survey and the ratio of correct answers to each question. In aggregate, 232 (39.2%) of respondents had a "low level" of knowledge, and 360 (60.8%) had a "high level" of 
